Athenex, Inc.

EDGAR

170 filing records in this dataset, filed from 2016-10-07 to 2023-04-28. Reported financial figures are available; chart coverage varies by period.

Watchlist

Latest quarter

Revenue

8.63 million USD

2022 Q4 · USD

Exact inputs and evidence

Operating margin

-159.1%

2022 Q4 · %

Exact inputs and evidence
  • Operating Income: -70014000 USD Source
  • Operating Income: -56279000 USD Source
  • Revenue: 102821000 USD Source
  • Revenue: 94188000 USD Source

Operating cash flow

-11.8 million USD

2022 Q4 · USD

Exact inputs and evidence
  • Operating Cash Flow: -64348000 USD Source
  • Operating Cash Flow: -52542000 USD Source
Cash and cash equivalents
30.4 million USD Source
Exact value

30400000 USD

Long-term debt including current maturities
737 thousand USD Source
Exact value

737000 USD

Shares outstanding
8.63 million shares Source
Exact value

8626769 shares

Reported share-count change

56.67% · 3.12 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 5506503 shares · 2021-12-31· Source
  • 8626769 shares · 2022-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

103 million USD

2022-01-01 – 2022-12-31

Exact inputs and evidence
  • Revenue: 29724000 USD · 2022-01-01 – 2022-03-31 Source
  • Revenue: 31516000 USD · 2022-04-01 – 2022-06-30 Source
  • Revenue: 33530000 USD · 2022-07-01 – 2022-09-30 Source
  • Revenue: 102821000 USD · 2022-01-01 – 2022-12-31 Source
  • Revenue: 94188000 USD · 2022-01-01 – 2022-09-30 Source

Net income

-103 million USD

2022-01-01 – 2022-12-31

Exact inputs and evidence
  • Net income: -17420000 USD · 2022-01-01 – 2022-03-31 Source
  • Net income: -32157000 USD · 2022-04-01 – 2022-06-30 Source
  • Net income: -19669000 USD · 2022-07-01 – 2022-09-30 Source
  • Net income: -103427000 USD · 2022-01-01 – 2022-12-31 Source
  • Net income: -69246000 USD · 2022-01-01 – 2022-09-30 Source

Operating cash flow

-64.3 million USD

2022-01-01 – 2022-12-31

Exact inputs and evidence
  • Operating cash flow: -18466000 USD · 2022-01-01 – 2022-03-31 Source
  • Operating cash flow: -36811000 USD · 2022-01-01 – 2022-06-30 Source
  • Operating cash flow: -18466000 USD · 2022-01-01 – 2022-03-31 Source
  • Operating cash flow: -52542000 USD · 2022-01-01 – 2022-09-30 Source
  • Operating cash flow: -36811000 USD · 2022-01-01 – 2022-06-30 Source
  • Operating cash flow: -64348000 USD · 2022-01-01 – 2022-12-31 Source
  • Operating cash flow: -52542000 USD · 2022-01-01 – 2022-09-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-04-28.

Financial data available through: 2022-12-31.

Coverage by financial measure
  • Revenue: 8 of 11 periods available· newest 2022-12-31
  • Operating income: 8 of 11 periods available· newest 2022-12-31
  • Net income: 8 of 11 periods available· newest 2022-12-31
  • Operating cash flow: 8 of 11 periods available· newest 2022-12-31
  • Capital expenditure: 8 of 11 periods available· newest 2022-12-31
  • Total assets: 8 of 11 periods available· newest 2022-12-31
  • Total liabilities: 8 of 11 periods available· newest 2022-12-31
  • Current assets: 8 of 11 periods available· newest 2022-12-31
  • Current liabilities: 8 of 11 periods available· newest 2022-12-31
  • Cash and cash equivalents: 8 of 11 periods available· newest 2022-12-31
  • Long-term debt including current maturities: 1 of 11 periods available· newest 2015-12-31
  • Shares outstanding: 8 of 11 periods available· newest 2022-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +7.8%

    Prior period

    USD 95.37 million

    –

    Current period

    USD 102.82 million

    –

    Exact inputs and evidence

    102821000 − 95369000 = 7452000 USD

    95369000 USD · 2021-01-01 – 2021-12-31

    Inspect prior input Prior source

    102821000 USD · 2022-01-01 – 2022-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +USD 96.34 million

    Prior period

    −USD 199.77 million

    –

    Current period

    −USD 103.43 million

    –

    Exact inputs and evidence

    -103427000 − -199768000 = 96341000 USD

    -199768000 USD · 2021-01-01 – 2021-12-31

    Inspect prior input Prior source

    -103427000 USD · 2022-01-01 – 2022-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 65.45 million

    Prior period

    −USD 129.8 million

    –

    Current period

    −USD 64.35 million

    –

    Exact inputs and evidence

    -64348000 − -129796000 = 65448000 USD

    -129796000 USD · 2021-01-01 – 2021-12-31

    Inspect prior input Prior source

    -64348000 USD · 2022-01-01 – 2022-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -12%

    Prior period

    USD 474,000

    –

    Current period

    USD 417,000

    –

    Exact inputs and evidence

    417000 − 474000 = -57000 USD

    474000 USD · 2021-01-01 – 2021-12-31

    Inspect prior input Prior source

    417000 USD · 2022-01-01 – 2022-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2022-01-01 – 2022-12-31

  • Revenue USD 102.82 million 100% of revenue
  • Cost of revenue USD 76.12 million 74% of revenue
  • Operating expenses USD 96.72 million 94% of revenue
  • Operating income −USD 70.01 million −68% of revenue
  • Tax, interest and other Derived USD 33.41 million 32% of revenue
  • Net income −USD 103.43 million −101% of revenue

Cash

  • Operating cash flow −USD 64.35 million −63% of revenue
  • Capital expenditure USD 417,000 0.4% of revenue
  • Free cash flow Derived −USD 64.77 million −63% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2015 Operating loss: operating costs were 464% of revenue.
  • 2016 Operating loss: operating costs were 517% of revenue.
  • 2017 Operating loss: operating costs were 389% of revenue.
  • 2018 Operating loss: operating costs were 242% of revenue.
  • 2019 Operating loss: operating costs were 218% of revenue.
  • 2020 Operating loss: operating costs were 183% of revenue.
  • 2021 Operating loss: operating costs were 258% of revenue.
  • 2022 Operating loss: operating costs were 168% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2015 2015-01-01 – 2015-12-3113944000 64652000 Derived -50708000 -108000 Derived -50600000 -37066000 Derived
Source
2016 2016-01-01 – 2016-12-3120551000 106298000 Derived -85747000 1968000 Derived -87715000 -49357000 Derived
Source
2017 2017-01-01 – 2017-12-3138043000 148031000 Derived -109988000 21182000 Derived -131170000 -86952000 Derived
Source
2018 2018-01-01 – 2018-12-3189100000 215918000 Derived -126818000 -9378000 Derived -117440000 -112708000 Derived
Source
2019 2019-01-01 – 2019-12-31101229000 220272000 Derived -119043000 4706000 Derived -123749000 -106695000 Derived
Source
2020 2020-01-01 – 2020-12-31144391000 264118000 Derived -119727000 26452000 Derived -146179000 -136380000 Derived
Source
2021 2021-01-01 – 2021-12-3195369000 245801000 Derived -150432000 49336000 Derived -199768000 -130270000 Derived
Source
2022 2022-01-01 – 2022-12-31102821000 172835000 Derived -70014000 33413000 Derived -103427000 -64765000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 102.8M 2022
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.155.9M117.0M78.0M39.0M0.0201520192022
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2015Revenue13944000
2016Revenue20551000
2017Revenue38043000
2018Revenue89100000
2019Revenue101229000
2020Revenue144391000
2021Revenue95369000
2022Revenue102821000

Revenue growth

Change in revenue from the same financial period one year earlier.

7.8% 2022
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.148%99%50%1%-47%201520192022
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2015Year over yearNo prior comparable period
2016Year over year47.4%
2017Year over year85.1%
2018Year over year134.2%
2019Year over year13.6%
2020Year over year42.6%
2021Year over year-34%
2022Year over year7.8%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -68.1% 2022
Net margin -100.6% 2022
Free cash flow margin -63% 2022
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.34%-90%-213%-337%-461%201520192022
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2015Operating margin-363.7%
2016Operating margin-417.2%
2017Operating margin-289.1%
2018Operating margin-142.3%
2019Operating margin-117.6%
2020Operating margin-82.9%
2021Operating margin-157.7%
2022Operating margin-68.1%
2015Net margin-362.9%
2016Net margin-426.8%
2017Net margin-344.8%
2018Net margin-131.8%
2019Net margin-122.2%
2020Net margin-101.2%
2021Net margin-209.5%
2022Net margin-100.6%
2015Free cash flow margin-265.8%
2016Free cash flow margin-240.2%
2017Free cash flow margin-228.6%
2018Free cash flow margin-126.5%
2019Free cash flow margin-105.4%
2020Free cash flow margin-94.5%
2021Free cash flow margin-136.6%
2022Free cash flow margin-63%

Operating cash flow

Cash generated by the company’s normal business operations.

USD -64.3M 2022
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.10.4M-27.3M-64.9M-102.5M-140.2M201520192022
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2015Operating cash flow-33756000
2016Operating cash flow-47870000
2017Operating cash flow-81512000
2018Operating cash flow-109387000
2019Operating cash flow-96981000
2020Operating cash flow-127758000
2021Operating cash flow-129796000
2022Operating cash flow-64348000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -64.8M 2022
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.10.9M-28.6M-68.2M-107.7M-147.3M201520192022
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2015Free cash flow-37066000
2016Free cash flow-49357000
2017Free cash flow-86952000
2018Free cash flow-112708000
2019Free cash flow-106695000
2020Free cash flow-136380000
2021Free cash flow-130270000
2022Free cash flow-64765000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

111.9% 2022
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.121%91%60%30%0%201520192022
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2015Liabilities / assets18.6%
2016Liabilities / assets67.3%
2017Liabilities / assets35.4%
2018Liabilities / assets44.3%
2019Liabilities / assets43.3%
2020Liabilities / assets57%
2021Liabilities / assets87.1%
2022Liabilities / assets111.9%

Current assets to current liabilities

Current assets divided by current liabilities.

1.09× 2022
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.5.07×3.81×2.54×1.27×0.00×201520192022
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2015Current assets / current liabilities3.7×
2016Current assets / current liabilities1.85×
2017Current assets / current liabilities1.86×
2018Current assets / current liabilities3.31×
2019Current assets / current liabilities3.23×
2020Current assets / current liabilities4.7×
2021Current assets / current liabilities1.39×
2022Current assets / current liabilities1.09×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2015 2015-01-01 – 2015-12-31
−USD 50.6 million
Exact value

Exact value: -50600000 USD

2015-01-01 – 2015-12-31: -50600000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 33.76 million
Exact value

Exact value: -33756000 USD

2015-01-01 – 2015-12-31: -33756000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 3.31 million
Exact value

Exact value: 3310000 USD

2015-01-01 – 2015-12-31: 3310000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 37.07 million
Calculation and evidence

-33756000 − 3310000 USD

Exact free cash flow: -37066000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2016 2016-01-01 – 2016-12-31
−USD 87.72 million
Exact value

Exact value: -87715000 USD

2016-01-01 – 2016-12-31: -87715000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 47.87 million
Exact value

Exact value: -47870000 USD

2016-01-01 – 2016-12-31: -47870000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.49 million
Exact value

Exact value: 1487000 USD

2016-01-01 – 2016-12-31: 1487000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 49.36 million
Calculation and evidence

-47870000 − 1487000 USD

Exact free cash flow: -49357000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2017 2017-01-01 – 2017-12-31
−USD 131.17 million
Exact value

Exact value: -131170000 USD

2017-01-01 – 2017-12-31: -131170000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 81.51 million
Exact value

Exact value: -81512000 USD

2017-01-01 – 2017-12-31: -81512000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 5.44 million
Exact value

Exact value: 5440000 USD

2017-01-01 – 2017-12-31: 5440000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 86.95 million
Calculation and evidence

-81512000 − 5440000 USD

Exact free cash flow: -86952000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2018 2018-01-01 – 2018-12-31
−USD 117.44 million
Exact value

Exact value: -117440000 USD

2018-01-01 – 2018-12-31: -117440000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 109.39 million
Exact value

Exact value: -109387000 USD

2018-01-01 – 2018-12-31: -109387000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 3.32 million
Exact value

Exact value: 3321000 USD

2018-01-01 – 2018-12-31: 3321000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 112.71 million
Calculation and evidence

-109387000 − 3321000 USD

Exact free cash flow: -112708000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2019 2019-01-01 – 2019-12-31
−USD 123.75 million
Exact value

Exact value: -123749000 USD

2019-01-01 – 2019-12-31: -123749000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 96.98 million
Exact value

Exact value: -96981000 USD

2019-01-01 – 2019-12-31: -96981000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 9.71 million
Exact value

Exact value: 9714000 USD

2019-01-01 – 2019-12-31: 9714000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 106.7 million
Calculation and evidence

-96981000 − 9714000 USD

Exact free cash flow: -106695000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2020 2020-01-01 – 2020-12-31
−USD 146.18 million
Exact value

Exact value: -146179000 USD

2020-01-01 – 2020-12-31: -146179000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 127.76 million
Exact value

Exact value: -127758000 USD

2020-01-01 – 2020-12-31: -127758000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 8.62 million
Exact value

Exact value: 8622000 USD

2020-01-01 – 2020-12-31: 8622000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 136.38 million
Calculation and evidence

-127758000 − 8622000 USD

Exact free cash flow: -136380000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
−USD 199.77 million
Exact value

Exact value: -199768000 USD

2021-01-01 – 2021-12-31: -199768000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 129.8 million
Exact value

Exact value: -129796000 USD

2021-01-01 – 2021-12-31: -129796000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 474,000
Exact value

Exact value: 474000 USD

2021-01-01 – 2021-12-31: 474000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 130.27 million
Calculation and evidence

-129796000 − 474000 USD

Exact free cash flow: -130270000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 103.43 million
Exact value

Exact value: -103427000 USD

2022-01-01 – 2022-12-31: -103427000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 64.35 million
Exact value

Exact value: -64348000 USD

2022-01-01 – 2022-12-31: -64348000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 417,000
Exact value

Exact value: 417000 USD

2022-01-01 – 2022-12-31: 417000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 64.77 million
Calculation and evidence

-64348000 − 417000 USD

Exact free cash flow: -64765000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

170 filings · 5,106 latest values · 5,106 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001300699, 1300699, ATNX, edgar:1300699

Also known as ATHENEX, INC., Athenex, Inc., Kinex Pharmaceuticals LLC, Kinex Pharmaceuticals, Inc.